Prestige Consumer Healthcare INC Form 4 insider transactions

Director John E. Byom acquired 2,202 restricted stock units of Prestige Consumer Healthcare Inc. on August 6, 2024, as part of the company's director compensation program.

Director John F. Kelly of Prestige Consumer Healthcare Inc. received restricted stock units on August 5th and 6th, 2024, according to a Form 4 filing.

Ronald M. Lombardi, CEO of Prestige Consumer Healthcare, reports acquisition of shares and restricted stock units.

Adel Mekhail, EVP of Marketing & Sales at Prestige Consumer Healthcare, acquired 3,020 shares of common stock through restricted stock units on May 7, 2024.

Senior VP Operations Jeffrey Zerillo reports the acquisition of 2,116 restricted stock units in Prestige Consumer Healthcare Inc.

Christine Sacco, CFO of Prestige Consumer Healthcare Inc., reports the acquisition of restricted stock units.

William P'Pool, SVP, General Counsel & Corp Secretary of Prestige Consumer Healthcare, acquired 3,123 shares of common stock through restricted stock units on May 7, 2024.

Mary Beth Fritz, SVP Quality & Regulatory at Prestige Consumer Healthcare, reports acquisition and disposal of company stock.

Mary Beth Fritz, SVP of Quality & Regulatory at Prestige Consumer Healthcare, reports acquisition and disposal of company stock following vesting of performance stock units.

Ronald M. Lombardi, CEO of Prestige Consumer Healthcare, settled performance stock units (PSUs) on May 6, 2024, acquiring 85,533 shares and disposing of 41,356 shares to cover tax obligations.

Jeffrey Zerillo, Senior VP Operations at Prestige Consumer Healthcare, settled performance stock units and disposed of shares to cover tax obligations.

Christine Sacco, CFO of Prestige Consumer Healthcare, reports acquisition and disposal of company stock related to performance stock units.

William P'Pool, SVP, General Counsel & Corp Secretary of Prestige Consumer Healthcare, reports acquisition and disposal of company stock related to performance stock units.

EVP of Marketing & Sales at Prestige Consumer Healthcare, Mekhail Adel, reports acquisition and disposal of company stock following the vesting of performance stock units.

Mary Beth Fritz, SVP Quality & Regulatory at Prestige Consumer Healthcare Inc., sold shares to cover tax obligations arising from vesting restricted stock units.

CEO Ronald M. Lombardi of Prestige Consumer Healthcare Inc. reports the disposal of common stock to cover tax obligations.

Jeffrey Zerillo, Senior VP Operations at Prestige Consumer Healthcare, disposed of shares to cover tax obligations arising from stock awards.

Christine Sacco, CFO of Prestige Consumer Healthcare Inc., reported the disposal of common stock shares on May 2nd and 3rd, 2024, to cover tax obligations.

William P'Pool, SVP, General Counsel & Corp Secretary of Prestige Consumer Healthcare, reported the disposal of common stock to cover tax obligations.

Adel Mekhail, EVP of Marketing & Sales at Prestige Consumer Healthcare, sold shares of common stock to cover tax obligations arising from vesting restricted stock units.

Mary Beth Fritz, SVP Quality & Regulatory at Prestige Consumer Healthcare, exercised stock options and sold shares on March 1, 2024.

Mary Beth Fritz, SVP Quality & Regulatory at Prestige Consumer Healthcare, exercised stock options and sold shares on February 27 and 28, 2024.

Mary Beth Fritz, SVP of Quality & Regulatory at Prestige Consumer Healthcare Inc., reports exercising stock options and selling shares on February 23 and 26, 2024.